Skip to main contentSkip to navigation
Sirius Investors

ROIX Stock: Response Oncology, Inc. Stock Price, Analysis & Insights

Get live ROIX stock price $0.00, comprehensive Response Oncology, Inc. stock analysis, charts, news, and expert forecast. Real-time ROIX stock data and investment insights.

0.00
0.00%Today
ROIXResponse Oncology, Inc. • Other OTC • Healthcare
Market Cap
12
Volume
500
52W High
0.00
52W Low
0.00

Loading chart data...

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Response Oncology, Inc., originally incorporated in Memphis, Tennessee, in 1984, has largely ceased its business activities and no longer maintains significant operations. By May 20, 2002, the company had completed the liquidation of most of its oper...

Company Information

CEO
Charles E. Sweet
Sector
Healthcare
Industry
Medical - Care Facilities
Employees
10

Contact Information

Website
Address
Country
US

Investment Analysis & Business Insights

Healthcare
Medical - Care Facilities

Investment Highlights

Strong presence in the Healthcare sector with established market position

Lower volatility stock (Beta: -19.14) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Response Oncology, Inc. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Response Oncology, Inc.
  • Investors should consider how Response Oncology, Inc. fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

12

P/E Ratio (TTM)

-0.00

Beta

-19.14

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.